Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
The Middle East respiratory syndrome coronavirus (MERS-CoV) is associated with life-threatening severe illnesses and a mortality rate of approximately 35%, particularly in patients with underlying comorbidities. A systematic analysis of 637 MERS-CoV cases suggests that diabetes and hypertension are...
Main Authors: | Alaa Badawi, Seung Gwan Ryoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-08-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971216311006 |
Similar Items
-
Prevalence of diabetes in the 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus: a systematic review and meta-analysis
by: Alaa Badawi, et al.
Published: (2016-12-01) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
by: Ahmad Tavakoli, et al.
Published: (2017-04-01) -
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
by: Abeer N. Alshukairi, et al.
Published: (2021-05-01) -
Laboratory Testing for Middle East Respiratory Syndrome Coronavirus, California, USA, 2013–2014
by: Mahtab Shahkarami, et al.
Published: (2015-09-01) -
Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus
by: Júlia Vergara-Alert, et al.
Published: (2017-02-01)